EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Universal Ibogaine's Enterprise Value is $10.39 Mil.
Universal Ibogaine's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2025 was $-0.48 Mil. Therefore, Universal Ibogaine's EV-to-FCF for today is -21.82.
The historical rank and industry rank for Universal Ibogaine's EV-to-FCF or its related term are showing as below:
IBOGF'
s EV-to-FCF Range Over the Past 10 Years
Min: -23.27 Med: 0 Max: 0
Current: -21.82
IBOGF's EV-to-FCF is not ranked
in the Biotechnology industry.
Industry Median: 16.36
vs IBOGF: -21.82
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Universal Ibogaine's PE Ratio (TTM) for today is calculated as:
Universal Ibogaine's share price for today is $0.0277.
Universal Ibogaine's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.015.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Universal Ibogaine EV-to-FCF Related Terms
Universal Ibogaine EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Universal Ibogaine's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Universal Ibogaine's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Universal Ibogaine EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Universal Ibogaine's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Universal Ibogaine's EV-to-FCF falls into.
Universal Ibogaine's current Enterprise Value is $10.39 Mil.
Universal Ibogaine's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.48 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Universal Ibogaine (IBOGF) has a EV-to-FCF of -21.82 as of Jul. 11, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Universal Ibogaine and its competitors.
Is Universal Ibogaine's EV-to-FCF too high?
Universal Ibogaine's current EV-to-FCF is -21.82.
How does Universal Ibogaine's EV-to-FCF compare to LABT and CALC?
Universal Ibogaine's EV-to-FCF of -21.82 can be compared against companies in the Biotechnology industry. The industry median EV-to-FCF is 16.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 16.36, based on 330 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Universal Ibogaine and its competitors. For the Biotechnology industry, the median EV-to-FCF is 16.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Universal Ibogaine's current EV-to-FCF is -21.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Ibogaine stock overvalued right now?
Universal Ibogaine (IBOGF) has a current EV-to-FCF of -21.82. The current EV-to-FCF is -21.82. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Universal Ibogaine (IBOGF), the current EV-to-FCF is -21.82 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IBOGF has been successfully added to your 